vs
Astrana Health, Inc.（ASTH）とCARPENTER TECHNOLOGY CORP（CRS）の財務データ比較。上の社名をクリックして会社を切り替えられます
Astrana Health, Inc.の直近四半期売上が大きい（$950.5M vs $811.5M、CARPENTER TECHNOLOGY CORPの約1.2倍）。CARPENTER TECHNOLOGY CORPの純利益率が高く（17.2% vs 0.7%、差は16.5%）。Astrana Health, Inc.の前年同期比売上増加率が高い（42.9% vs 11.6%）。過去8四半期でAstrana Health, Inc.の売上複合成長率が高い（53.3% vs 0.8%）
アストラナヘルス社は米国に本拠を置く価値基準型医療サービスプロバイダーで、主に米国全土の連邦医療保険対象高齢者層にサービスを提供している。訪問型プライマリケア、慢性疾患管理、ケアコーディネーションを通じ、患者の健康状態改善と不要な医療費削減を目指している。
カーペンター・テクノロジー・コーポレーションは、ステンレス鋼、耐食性ニッケル・銅・チタン合金、3D積層造形用粉末合金の開発・製造・流通を手掛ける。2018年度の売上構成は航空宇宙・防衛55%、産業・消費財17%、医療8%、運輸7%、エネルギー7%、流通6%となっている。
ASTH vs CRS — 直接比較
損益計算書 — Q4 FY2025 vs Q3 FY2026
| 指標 | | |
|---|---|---|
| 売上 | $950.5M | $811.5M |
| 純利益 | $6.6M | $139.6M |
| 粗利率 | — | 31.0% |
| 営業利益率 | 1.9% | 23.0% |
| 純利益率 | 0.7% | 17.2% |
| 売上前年比 | 42.9% | 11.6% |
| 純利益前年比 | 184.4% | 46.3% |
| EPS（希薄化後） | $0.12 | $2.77 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q1 26 | — | $811.5M | ||
| Q4 25 | $950.5M | $728.0M | ||
| Q3 25 | $956.0M | $733.7M | ||
| Q2 25 | $654.8M | $755.6M | ||
| Q1 25 | $620.4M | $727.0M | ||
| Q4 24 | $665.2M | $676.9M | ||
| Q3 24 | $478.7M | $717.6M | ||
| Q2 24 | $486.3M | $798.7M |
| Q1 26 | — | $139.6M | ||
| Q4 25 | $6.6M | $105.3M | ||
| Q3 25 | $373.0K | $122.5M | ||
| Q2 25 | $9.4M | $111.7M | ||
| Q1 25 | $6.7M | $95.4M | ||
| Q4 24 | $-7.8M | $84.1M | ||
| Q3 24 | $16.1M | $84.8M | ||
| Q2 24 | $19.2M | $93.6M |
| Q1 26 | — | 31.0% | ||
| Q4 25 | — | 30.0% | ||
| Q3 25 | — | 29.5% | ||
| Q2 25 | — | 28.3% | ||
| Q1 25 | — | 27.6% | ||
| Q4 24 | — | 26.2% | ||
| Q3 24 | — | 24.6% | ||
| Q2 24 | — | 23.9% |
| Q1 26 | — | 23.0% | ||
| Q4 25 | 1.9% | 21.3% | ||
| Q3 25 | 2.0% | 20.9% | ||
| Q2 25 | 3.1% | 20.1% | ||
| Q1 25 | 3.3% | 19.0% | ||
| Q4 24 | 0.1% | 17.6% | ||
| Q3 24 | 5.9% | 15.8% | ||
| Q2 24 | 6.2% | 13.6% |
| Q1 26 | — | 17.2% | ||
| Q4 25 | 0.7% | 14.5% | ||
| Q3 25 | 0.0% | 16.7% | ||
| Q2 25 | 1.4% | 14.8% | ||
| Q1 25 | 1.1% | 13.1% | ||
| Q4 24 | -1.2% | 12.4% | ||
| Q3 24 | 3.4% | 11.8% | ||
| Q2 24 | 3.9% | 11.7% |
| Q1 26 | — | $2.77 | ||
| Q4 25 | $0.12 | $2.09 | ||
| Q3 25 | $0.01 | $2.43 | ||
| Q2 25 | $0.19 | $2.21 | ||
| Q1 25 | $0.14 | $1.88 | ||
| Q4 24 | $-0.14 | $1.66 | ||
| Q3 24 | $0.33 | $1.67 | ||
| Q2 24 | $0.40 | $1.85 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $429.5M | $294.8M |
| 総負債低いほど良い | — | $690.4M |
| 株主資本純資産 | $779.3M | $2.1B |
| 総資産 | $2.2B | $3.7B |
| 負債/資本比率低いほどレバレッジが低い | — | 0.33× |
8四半期トレンド — 暦四半期で整列
| Q1 26 | — | $294.8M | ||
| Q4 25 | $429.5M | $231.9M | ||
| Q3 25 | $463.4M | $208.0M | ||
| Q2 25 | $342.1M | $315.5M | ||
| Q1 25 | $260.9M | $151.5M | ||
| Q4 24 | $290.8M | $162.1M | ||
| Q3 24 | $350.3M | $150.2M | ||
| Q2 24 | $327.7M | $199.1M |
| Q1 26 | — | $690.4M | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | $2.1B | ||
| Q4 25 | $779.3M | $2.0B | ||
| Q3 25 | $775.5M | $1.9B | ||
| Q2 25 | $765.5M | $1.9B | ||
| Q1 25 | $745.4M | $1.8B | ||
| Q4 24 | $712.7M | $1.7B | ||
| Q3 24 | $704.6M | $1.7B | ||
| Q2 24 | $678.9M | $1.6B |
| Q1 26 | — | $3.7B | ||
| Q4 25 | $2.2B | $3.5B | ||
| Q3 25 | $2.2B | $3.4B | ||
| Q2 25 | $1.4B | $3.5B | ||
| Q1 25 | $1.3B | $3.4B | ||
| Q4 24 | $1.4B | $3.3B | ||
| Q3 24 | $1.3B | $3.3B | ||
| Q2 24 | $1.3B | $3.3B |
| Q1 26 | — | 0.33× | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $-2.9M | — |
| フリーキャッシュフロー営業CF - 設備投資 | $-6.0M | — |
| FCFマージンFCF / 売上 | -0.6% | — |
| 設備投資強度設備投資 / 売上 | 0.3% | — |
| キャッシュ転換率営業CF / 純利益 | -0.44× | — |
| 直近12ヶ月FCF直近4四半期 | $104.5M | — |
8四半期トレンド — 暦四半期で整列
| Q1 26 | — | — | ||
| Q4 25 | $-2.9M | $132.2M | ||
| Q3 25 | $10.0M | $39.2M | ||
| Q2 25 | $90.9M | $258.1M | ||
| Q1 25 | $16.6M | $74.2M | ||
| Q4 24 | $-10.9M | $67.9M | ||
| Q3 24 | $34.0M | $40.2M | ||
| Q2 24 | $23.2M | $169.5M |
| Q1 26 | — | — | ||
| Q4 25 | $-6.0M | $85.9M | ||
| Q3 25 | $7.4M | $-3.4M | ||
| Q2 25 | $89.5M | $200.2M | ||
| Q1 25 | $13.6M | $34.0M | ||
| Q4 24 | $-13.5M | $38.6M | ||
| Q3 24 | $31.7M | $13.3M | ||
| Q2 24 | $20.4M | $141.8M |
| Q1 26 | — | — | ||
| Q4 25 | -0.6% | 11.8% | ||
| Q3 25 | 0.8% | -0.5% | ||
| Q2 25 | 13.7% | 26.5% | ||
| Q1 25 | 2.2% | 4.7% | ||
| Q4 24 | -2.0% | 5.7% | ||
| Q3 24 | 6.6% | 1.9% | ||
| Q2 24 | 4.2% | 17.8% |
| Q1 26 | — | — | ||
| Q4 25 | 0.3% | 6.4% | ||
| Q3 25 | 0.3% | 5.8% | ||
| Q2 25 | 0.2% | 7.7% | ||
| Q1 25 | 0.5% | 5.5% | ||
| Q4 24 | 0.4% | 4.3% | ||
| Q3 24 | 0.5% | 3.7% | ||
| Q2 24 | 0.6% | 3.5% |
| Q1 26 | — | — | ||
| Q4 25 | -0.44× | 1.26× | ||
| Q3 25 | 26.69× | 0.32× | ||
| Q2 25 | 9.65× | 2.31× | ||
| Q1 25 | 2.48× | 0.78× | ||
| Q4 24 | — | 0.81× | ||
| Q3 24 | 2.11× | 0.47× | ||
| Q2 24 | 1.21× | 1.81× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
CRS
| Aerospace and Defense | $435.6M | 54% |
| Surcharge revenue | $155.9M | 19% |
| Industrial and Consumer | $78.1M | 10% |
| Medical | $51.7M | 6% |
| Energy | $50.5M | 6% |
| Distribution | $20.4M | 3% |
| Transportation | $19.3M | 2% |
